Description
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
| Purity | ≥70% |
|---|---|
| Formula | C16H14N2O4 |
| Formula Wt. | 298.29 |
| Appearance | Red Powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
CDK4/6 inhibitor.
Laminin-derived nonapeptide.
ITC, used as chiral agent.
Alkaloid found in Catharanthus, precursor in sy...
Synthetic peptide, retroviral envelope protein ...
Hydroxycinnamic aicd, verbascoside metabolite, ...
5-Fluorouracil prodrug, pyrimidine nucleoside a...
5-Lipoxygenase inhibitor.
ALK and IGF-1R inhibitor.
p110α PI3K inhibitor.
Reversible DNMT1-selective inhibitor
Triadimefon metabolite; mutagen.
R-type Ca2+ and voltage-gated Na+ channel block...
SYK/JAK inhibitor
EZH2 inhibitor
Steroidal alkaloid found in Fritillaria; M2 mAC...
Fluorinated aminopropyl carbazole, neuroprotect...
Neutrophil elastase inhibitor.
PIKfyve inhibitor.
Selective inhibitor of PI3Kβ and PI3Kδ.